Clinical Trial Update: Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enzastaurin with radiation followed by enzastaurin in newly diagnosed glioblastoma; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2019-04-05